Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
BESPONSA Trockensub 1 mg Durchstf
Drug
Besponsa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
akute lymphoblastische Leukämie
07.16.1. – cytostatics
HAM – Human medicine
PULPA – Powder for parenteral solution
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
7/10/2017
12/31/9999
Dosage strength
Besponsa 1mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
akute lymphoblastische Leukämie
01
Z – approved
Package
7680660220012
In trade from / since 7/10/2017
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
1 mg inotuzumabum ozogamicinum
trometamolum
saccharum
polysorbatum 80
natrii chloridum
0.9441 mg natrium
saccharum
polysorbatum 80
natrii chloridum
0.9441 mg natrium
Spezialitätenliste***
SL
-
-
11762.85
None
Yes
10%
No
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.